[{"NetIncomeLoss_2_Q2_USD":-40657000.0,"DepreciationAndAmortization_2_Q2_USD":991000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":32480000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":32595000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":6624000.0,"PaymentsToAcquireShortTermInvestments_2_Q2_USD":86109000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":95000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":31000000.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-36786000.0,"AssetsCurrent_0_Q2_USD":159455000.0,"IncreaseDecreaseInPrepaidExpensesOther_2_Q2_USD":-350000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":45697000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":19497000.0,"AccountsReceivableGrossCurrent_0_Q2_USD":7925000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":10587000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":10587000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":728000.0,"CommonStockSharesIssued_0_Q2_shares":32645.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":5601000.0,"AmortizationOfLeasedAsset_2_Q2_USD":1078000.0,"Assets_0_Q2_USD":176782000.0,"ShareBasedCompensation_1_Q2_USD":3632000.0,"ConvertibleLongTermNotesPayable_0_Q2_USD":63874000.0,"EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_0_Q2_USD":3596000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":12059000.0,"InterestPayableCurrentAndNoncurrent_0_Q2_USD":400000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":61000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":42000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-1149000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-1546000.0,"AccountsReceivableNetCurrent_0_Q2_USD":7653000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_2_Q2_USD":92000.0,"CommonStockValue_0_Q2_USD":33000.0,"Revenues_2_Q2_USD":29606000.0,"Revenues_1_Q2_USD":9780000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":-4639000.0,"ShareBasedCompensation_2_Q2_USD":7988000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":65790000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_0_Q2_USD":4722000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-2844000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-40615000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-23063000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1467000.0,"OtherAssetsNoncurrent_0_Q2_USD":533000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":29458000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":9645000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":360396000.0,"Liabilities_0_Q2_USD":87671000.0,"DerivativeFairValueOfDerivativeLiability_0_Q2_USD":70700000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":4018000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":10901000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":3829000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-11460000.0,"SeniorLongTermNotes_0_Q2_USD":63874000.0,"CommonStockSharesOutstanding_0_Q2_shares":32645.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"DebtInstrumentInterestRateEffectivePercentage_0_Q2_pure":0.058,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3586000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-20198000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":1782000.0,"OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities_2_Q2_USD":0.0,"CostOfRevenue_2_Q2_USD":13767000.0,"CostOfRevenue_1_Q2_USD":7357000.0,"LiabilitiesCurrent_0_Q2_USD":14130000.0,"AccountsPayableCurrent_0_Q2_USD":2616000.0,"InterestExpense_2_Q2_USD":486000.0,"InterestExpense_1_Q2_USD":486000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":1964000.0,"GrossProfit_2_Q2_USD":15839000.0,"GrossProfit_1_Q2_USD":2423000.0,"ProceedsFromDebtNetOfIssuanceCosts_2_Q2_USD":61961000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":131000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":5893000.0,"NetIncomeLoss_1_Q2_USD":-23124000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":8806000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-271413000.0,"AmortizationOfFinancingCostsAndDiscounts_2_Q2_USD":117000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_2_Q2_USD":49856000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.001,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"CommonStockSharesAuthorized_0_Q2_shares":150000.0,"OperatingIncomeLoss_2_Q2_USD":-39022000.0,"OperatingIncomeLoss_1_Q2_USD":-21092000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":106373000.0,"InventoryNet_0_Q2_USD":14007000.0,"PreferredStockValue_0_Q2_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":176782000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":8077000.0,"PreferredStockSharesAuthorized_0_Q2_shares":9994.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.001,"OperatingLeaseLiabilityCurrent_0_Q2_USD":2414000.0,"OperatingExpenses_1_Q2_USD":23515000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-1.25,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.71,"OtherLiabilitiesNoncurrent_0_Q2_USD":22000.0,"OtherLiabilitiesCurrent_0_Q2_USD":3437000.0,"StockholdersEquity_0_Q2_USD":89111000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":533000.0,"DebtInstrumentCarryingAmount_0_Q2_USD":65000000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":272000.0,"LongTermInvestments_0_Q2_USD":0.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":33000.0,"OperatingExpenses_2_Q2_USD":54861000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":9164000.0,"Ticker":"XENT","CIK":"1271214","name":"INTERSECT ENT, INC.","OfficialName":"Intersect ENT Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"945036515.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"nan","filed":"20200805"}]